Physician profile
Maheep Sohal
NPI 1871939553
$9,642.06
in general payments reported to CMS, 2019-2025
20 companies · $4,089 in 2025
The $4,089 reported for 2025 was more than what 95% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,646 · 2020: $333 · 2021: $70.99 · 2022: $1,046 · 2023: $1,203 · 2024: $253 · 2025: $4,089.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,570 · Food and Beverage: $1,622 · Travel and Lodging: $353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,570.00 |
| Food and Beverage | $1,621.84 |
| Travel and Lodging | $353.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,092.91 | 2021-2025 | Fusion, Propel |
| Intersect Ent, INC. | $2,839.74 | 2019-2022 | |
| Aerin Medical INC. | $918.72 | 2022-2025 | |
| Inspire Medical Systems, INC. | $657.70 | 2022-2025 | Inspire |
| Stryker Corporation | $337.19 | 2022-2025 | Na, Sonopet Iq, Core |
| Glaxosmithkline, LLC. | $217.21 | 2022-2025 | Nucala |
| Karl Storz Endoscopy-America | $102.84 | 2022 | |
| Medtronic USA, INC. | $97.42 | 2020 | |
| Optinose US, INC. | $77.67 | 2020-2022 | |
| Pfizer INC. | $66.94 | 2023 | |
| Kaleo, INC. | $43.37 | 2020 | |
| Neurent Medical Limited | $37.12 | 2024 | Neuromark Device, Neuromark Radiofrequency Console |
| Davol INC. | $26.29 | 2023 | Arista Ah Flexitip |
| Convatec INC. | $23.49 | 2024 | |
| Biocryst US Sales Co., LLC | $21.99 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Respicardia, INC. | $18.49 | 2024 | Remede System |
| Smith+Nephew, INC. | $17.71 | 2025 | Tula |
| Regeneron Healthcare Solutions, INC. | $17.51 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.02 | 2022 | |
| Tactile Systems Technology INC | $12.73 | 2023 | Flexitouch Plus, Entre Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maheep Sohal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.